ArticleStem cell reviews and reports2025

Empagliflozin Reduces High Glucose-Induced Cardiomyopathy in hiPSC-Derived Cardiomyocytes : Glucose-induced Lipotoxicity in hiPSC-Derived Cardiomyocytes.

Hsiu-Hui Tsai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.